Drug Type Monoclonal antibody |
Synonyms RO-5323441, RO5323441, TB 403 + [1] |
Target |
Mechanism PIGF inhibitors(Phosphatidylinositol glycan synthesis F inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Phase 1 | DK | 01 May 2011 | |
Glioblastoma Multiforme | Phase 1 | FR | 01 May 2011 | |
Glioblastoma Multiforme | Phase 1 | CH | 01 May 2011 | |
Glioblastoma Multiforme | Phase 1 | GB | 01 May 2011 | |
Recurrent Glioblastoma | Phase 1 | DK | 01 May 2011 | |
Recurrent Glioblastoma | Phase 1 | FR | 01 May 2011 | |
Recurrent Glioblastoma | Phase 1 | CH | 01 May 2011 | |
Recurrent Glioblastoma | Phase 1 | GB | 01 May 2011 | |
Solid tumor | Phase 1 | DK | 01 Jun 2008 | |
Solid tumor | Phase 1 | DK | 01 Jun 2008 |
AACR2021 Manual | Phase 1 | 15 | ihijddfvgi(mpbvlskehz) = oomwwnohhf vhvhwixkms (zwixlcbuit ) | Positive | 10 Apr 2021 | ||
Phase 1 | 22 | euqicbxdnw(stovtdpfvr) = wlajnhdbge hkfunwblfa (taonsmkdxu ) | - | 20 May 2013 |